BridgeMD
Prevention study for Ischemic Stroke
Official title Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System
ClinicalTrials.gov ID: NCT06783049
What this study is testing
- What it's testing
- The purpose of this study is to develop a digital health-based intelligent management system for the secondary prevention of ischemic stroke and to evaluate its effectiveness through a multicenter randomized controlled trial, assessing its health economic value. Participants will receive usual care after discharge (control group) or be managed with a WeChat-based intelligent management system after discharge (intervention group).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years.
- Patients diagnosed with acute ischemic stroke or transient ischemic attack.
- Time from onset to enrollment ≤ 14 days.
- Presence of at least one modifiable risk factor (hypertension, diabetes).
- Ability to independently use a smartphone to complete system tasks upon discharge, or with the assistance of family members.
You likely can't join if
- Patients already enrolled in other stroke-related healthcare quality improvement projects or clinical trials.
- Patients or family members who refuse to sign the informed consent form.
- Pregnant or breastfeeding women.
See the full eligibility criteria
- Age ≥ 18 years.
- Patients diagnosed with acute ischemic stroke or transient ischemic attack.
- Time from onset to enrollment ≤ 14 days.
- Presence of at least one modifiable risk factor (hypertension, diabetes).
- Ability to independently use a smartphone to complete system tasks upon discharge, or with the assistance of family members.
- Signed informed consent by the patient or their family members.
- Patients already enrolled in other stroke-related healthcare quality improvement projects or clinical trials.
- Patients or family members who refuse to sign the informed consent form.
- Pregnant or breastfeeding women.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
- Shihezi, Xinjiang, China
- Beijing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China; Shihezi, Xinjiang, China; Beijing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.